Tumor immunotherapy resistance: Revealing the mechanism of PD-1 / PD-L1-mediated tumor immune escape

Tumor immunotherapy, an innovative anti-cancer therapy, has showcased encouraging outcomes across diverse tumor types. Among these, the PD-1/PD-L1 signaling pathway is a well-known immunological checkpoint, which is significant in the regulation of immune evasion by tumors. Nevertheless, a considera...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Biomedicine & pharmacotherapy 2024-02, Vol.171, p.116203-116203, Article 116203
Hauptverfasser:	Cui, Jia-Wen, Li, Yao, Yang, Yang, Yang, Hai-Kui, Dong, Jia-Mei, Xiao, Zhi-Hua, He, Xin, Guo, Jia-Hao, Wang, Rui-Qi, Dai, Bo, Zhou, Zhi-Ling
Format:	Artikel
Sprache:	eng
Schlagworte:	Anti-PD-1/PD-L1 therapy Immune escape Immunotherapy resistance PD-1/PD-L1 Tumor immunotherapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!